// App-Quantinova.ai

2282 : Decitabine response in FLT3-negative AML is associated with mitochondrial priming

Researchers

Presenter

  • Elisha Dettman

Principal Investigators

  • Camille Doykan

  • Jo Ishizawa

  • Weiguo Zhang

  • Alison Walker

  • William Blum

  • Rebecca Klisovic

  • Michael Cardone

  • Michael Andreeff

  • Amy Johnson

Medical Centers

  • Eutropics Pharmaceuticals, Cambridge, MA

  • 1.MD Anderson Cancer Center, Houston, TX

  • The Ohio State Univerisity, Columbus, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

  • Solid malignancies

Biomarkers

  • B-cell lymphoma 2

Drug/Treatment

  • Decitabine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved